CD19 expression on bone marrow hematogones and blasts following anti-CD19 therapy in B-ALL: a descriptive single-center analysis

Leukemia & lymphoma/Leukemia and lymphoma 2026

View at publisher
Authors: Gabriele Schiaffini, Giacomo Di Cesare, Elisabetta Metafuni, Elena Maiolo, Maria Assunta Limongiello, Sabrina Giammarco, Filippo Frioni, Camilla Iacovelli, Simone D’Innocenzo, Alessia Toscano, Gessica Minnella, Federica Sora'
+4 more Valerio De Stefano, Simona Sica, Patrizia Chiusolo, Silvia Bellesi
DOI: 10.1080/10428194.2026.2628197
Cited by: 0
References: 12

Abstract

To the editor,B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive malignancy of precursor B lymphoblasts. CD19-targeted immunotherapies, including bispecific T-cell engagers such as blinat...

Fields of Study & Subjects

CAR-T cell therapy research Acute Lymphoblastic Leukemia research Protein Degradation and Inhibitors

Publication details

Journal / source
Leukemia & lymphoma/Leukemia and lymphoma
Volume
67
Issue
6
Pages
1435–1439
Publication date
10 February 2026
Language
EN